Cargando…

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response

Detalles Bibliográficos
Autores principales: Marotte, H, Miossec, P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833616/
http://dx.doi.org/10.1186/ar679
_version_ 1782178428350365696
author Marotte, H
Miossec, P
author_facet Marotte, H
Miossec, P
author_sort Marotte, H
collection PubMed
description
format Text
id pubmed-2833616
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28336162010-03-08 Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response Marotte, H Miossec, P Arthritis Res Ther Meeting Abstract BioMed Central 2003 2003-02-24 /pmc/articles/PMC2833616/ http://dx.doi.org/10.1186/ar679 Text en
spellingShingle Meeting Abstract
Marotte, H
Miossec, P
Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title_full Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title_fullStr Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title_full_unstemmed Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title_short Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
title_sort circulating bioactive tnf in rheumatoid arthritis patients treated with infliximab: link to clinical response
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833616/
http://dx.doi.org/10.1186/ar679
work_keys_str_mv AT marotteh circulatingbioactivetnfinrheumatoidarthritispatientstreatedwithinfliximablinktoclinicalresponse
AT miossecp circulatingbioactivetnfinrheumatoidarthritispatientstreatedwithinfliximablinktoclinicalresponse